Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through clinical trials. While the Bay Area biotech has yet to set ...
Pioneering gene-editing treatments are already in clinical use, saving lives and easing the pain of devastating genetic diseases. However, the growing number of patients receiving these treatments ...
Prime Medicine, Inc. wins arbitration vs. Beam Therapeutics Inc., advancing PM647 for AATD. Read more on PRME and BEAM stocks ...
Data presented at EULAR 2026 confirm that tight disease control can lead to safe pregnancies but also expose a critical need ...
Spread the love“`html In an age where technology is advancing at breakneck speed, understanding the impact of modern ...
King Faisal Specialist Hospital and Research Centre in Jeddah has successfully developed and implemented the world's first protocol of its kind, using an algorithm to accurately estimate the expected ...
The future of cell and gene therapy may be defined less by discoveries and more by how the industry connects research and ...
The speed at which a cell produces proteins is a decisive factor in determining whether it divides, specializes or retains ...
In a study published in Science Translational Medicine, a team of researchers led by Dr. Wang Yu from the Shenzhen Institutes ...
Biohub researchers have performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, ...
When Dolly the sheep – the first cloned mammal – was born 30 years ago, she became one of the most famous animals in science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results